Based on the available information, this event is deemed to be a reportable malfunction.No patient harm was reported.Additional details have been requested but not provided to date.Should additional information become available, a follow-up report will be submitted.(b)(4).
|
This supplemental report is being submitted to correct the mfr report# for follow-up report#01 to 9680866-2016-00092, which was transcribed incorrectly during submission on january 19, 2017 in error.The last three (3) product monitoring reviews (pmrs) were reviewed and none of the affected product codes have illustrated any trends for product category or any malfunction or any harms.More specifically, there were no trends observed for the oxygen masks.Complaints spanning october 27, 2014 to october 27, 2016 (2 years) were reviewed as it related to reports of poor performance and cutting off oxygen flow, total of one (1) complaint was reported.No trends were observed and no harms reported.In all cases, the product was discontinued and replaced.This issue will be monitored through the post market product monitoring review process.No additional patient/event details have been provided to date.Should additional information become available, a follow-up report will be submitted.Reported to the fda on march 21, 2017.(b)(4).
|